drugs glp-1 Drugs: Fighting Diabetes and Weight Gainπ - General Comparing Ozempic, Wegovy and Other
Description
Novo Nordisk currently dominates the market with semaglutide (Rybelsus), but its patent on Wegovy and Ozempic expires in 2026, opening opportunities for generics
The brand-name version, Adipex-P, costs around $110 per month but offers no clinical advantage over generics
notably, subgroup analyses of placebo-controlled trials demonstrated a significant reduction in both colorectal and overall cancer risk [10]
Schwartz R, Kliper E, Stern N, Dotan G, Berliner S, Kesler A
Discover our difference
